Cargando…
Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?
Cancer patients are traditionally considered at high risk for complicated respiratory viral infections, due to their underlying immunosuppression. In line with this notion, early case series reported high mortality rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in pa...
Autores principales: | Chamilos, Georgios, Lionakis, Michail S, Kontoyiannis, Dimitrios P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454377/ https://www.ncbi.nlm.nih.gov/pubmed/33501958 http://dx.doi.org/10.1093/cid/ciaa1079 |
Ejemplares similares
-
Evaluating the Long-term Efficacy of Coronavirus Disease 2019 (COVID-19) Vaccines
por: Lin, Dan-Yu, et al.
Publicado: (2021) -
Evaluating the Efficacy of Coronavirus Disease 2019
Vaccines
por: Lin, Dan-Yu, et al.
Publicado: (2020) -
Impact of Molecular Syndromic Diagnosis of Severe Pneumonia in the Management of Critically Ill Patients
por: Stafylaki, Dimitra, et al.
Publicado: (2022) -
Hunting coronavirus severe acute respiratory syndrome coronavirus 2 (2019 novel coronavirus): From laboratory testing back to basic research
por: Yang, De-Ming, et al.
Publicado: (2020) -
Evaluating the Efficacy of Therapies in Patients With Coronavirus Disease 2019
por: Lin, Dan-Yu, et al.
Publicado: (2020)